Startup · $3m raised
Melbourne, VIC
Every investor coverage indicates participated in a round dorsaVi raised.
| Investor | Rounds | Invested |
|---|---|---|
| 62 Capital | Unnamed stage | - |
Investors whose own portfolio pages list dorsaVi, even though we haven't found any coverage of the round yet.
| Investor | Listed on |
|---|---|
| Starfish Ventures | its portfolio page ↗ |
Companies dorsaVi acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Dr Andrew Ronchi | Chief Executive | @AuManufacturing |
| Gernot Abl | Chairman | Biotech Dispatch, Dealroom |
Stories naming dorsaVi. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
ASX-listed Melbourne sensor maker dorsaVi has raised US$1.94 million in a post-IPO placement backed by 62 Capital, to expand its movement-data library and advance neuromorphic and RRAM chip development.
Also Biotech Dispatch
Australian wearable-sensor maker dorsaVi has built a beta spinal movement sensor with Medtronic after eighteen months of collaboration, and the two firms have extended their partnership toward commercialisation.